Background The airway inflammation observed in asthma is orchestrated by ac
tivated Th-2 lymphocytes relevant for the induction of altered airway respo
nsiveness. An increasing body of evidence is accumulating that not only the
pro-inflammatory cytokines interleukin (IL)-4 and IL-5 but also the immuno
modulating cytokines IL-12 and possibly IL-10 are crucial for regulating th
e allergic airway inflammation.
Objective Since IL-10 is capable of downregulating a broad spectrum of pro-
inflammatory cytokines, we wanted to address the role of endogenously produ
ced IL-10 in vivo in allergic asthma.
Methods Knockout (IL-10(-/-)) mice (C57BL/6-IL10tm1Cgn) and wild-type (WT)
counterparts were immunized (day 0) and exposed (day 14-21) to ovalbumin (O
VA). Airway inflammation and reactivity (AR), serum allergen-specific IgE r
esponses and cytokine profiles in the bronchoalveolar lavage fluid (BALF) w
ere studied.
Results The IL-10(-/-) mice had more eosinophilic airway inflammation but c
omparable levels of allergen-specific serum IgE compared to the WT mice aft
er allergen challenge. The AR was comparably increased in the OVA challenge
d WT and IL-10(-/-) mice vs sham-exposed WT, but not vs sham-exposed IL-10(
-/-) mice since these showed a higher baseline AR. IFN gamma, IL-4 and IL-1
3 were comparable and IL-5 was even lower in the BALF of the in IL-10(-/-)
mice compared to the similarly exposed WT mice.
Conclusion These results indicate that IL-10 plays an important and possibl
y direct role in the control of airway inflammation and responsiveness in a
n in vivo mouse model of allergy.